Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer.
Cochrane Database Syst Rev. 2011;2:CD006649
Authors: Akl EA, Vasireddi SR, Gunukula S, Barba M, Sperati F, Terrenato I, Muti P, Schünemann H
Compared to patients without cancer, patients with cancer who receive anticoagulant treatment for venous thromboembolism are more likely to develop recurrent venous thromboembolism (VTE).
PMID: 21328285 [PubMed - in process]